Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Assessment of endothelial function in the patient with erectile dysfunction: an opportunity for the urologist

International Journal of Impotence Research volume 20, pages 370–377 (2008)Cite this article

Abstract

Although there is now ample evidence that men with manifest coronary, cerebral and peripheral vascular disease and their risk factors are at highest risk for suffering from erectile dysfunction, recent findings demonstrate a strong connection between erectile dysfunction and endothelial dysfunction. This review explores how urologists and other providers may utilize the link between these conditions in clinical practice, compares methods of assessing endothelial dysfunction and finally speculates on how this additional information might impact treatment plans.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  PubMed  Google Scholar 

  2. Platano G, Margraf J, Alder J, Bitzer J . Frequency and focus of sexual history taking in male patients—a pilot study conducted among Swiss general practitioners and urologists. J Sex Med 2008; 5: 47–59.

    PubMed  Google Scholar 

  3. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180–189.

    CAS  PubMed  Google Scholar 

  4. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22–26.

    PubMed  Google Scholar 

  5. Gazzaruso C, Pujia A, Solerte SB, Amici ED, Emanuele E, Falcone C et al. Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int J Impot Res 2006; 18: 311–315.

    CAS  PubMed  Google Scholar 

  6. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003; 44: 360–364; discussion 364–365.

    PubMed  Google Scholar 

  7. Montorsi P, Ravagnani PM, Galli S, Salonia A, Briganti A, Werba JP et al. Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur Urol 2006; 50: 721–731.

    PubMed  Google Scholar 

  8. Vlachopoulos C, Rokkas K, Ioakeimidis N, Aggeli C, Michaelides A, Roussakis G et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur Urol 2005; 48: 996–1002; discussion 1002–1003.

    PubMed  Google Scholar 

  9. Borgquist R, Nilsson PM, Gudmundsson P, Winter R, Leosdottir M, Willenheimer R . Coronary flow velocity reserve reduction is comparable in patients with erectile dysfunction and in patients with impaired fasting glucose or well-regulated diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007; 14: 258–264.

    PubMed  Google Scholar 

  10. Borgquist R, Gudmundsson P, Winter R, Nilsson P, Willenheimer R . Erectile dysfunction in healthy subjects predicts reduced coronary flow velocity reserve. Int J Cardiol 2006; 112: 166–170.

    PubMed  Google Scholar 

  11. Solomon H, Man JW, Wierzbicki AS, Jackson G . Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 2003; 91: 230–231.

    PubMed  Google Scholar 

  12. Nurkalem Z, Kaya C, Orhan AL, Zencirci E, Alper AT, Kucuk E et al. Erectile dysfunction and coronary slow flow: distinct presentations of endothelial disease. Int J Impot Res 2007; 19: 610–614.

    CAS  PubMed  Google Scholar 

  13. Pritzker M . The penile stress test: a window to the hearts of man? Circulation 1999; 100 (Suppl 1): I-711; abstract 3751.

    Google Scholar 

  14. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA . Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996–3002.

    Article  CAS  PubMed  Google Scholar 

  15. Heidler S, Temml C, Broessner C, Mock K, Rauchenwald M, Madersbacher S et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol 2007; 177: 651–654.

    PubMed  Google Scholar 

  16. Nikoobakht M, Nasseh H, Pourkasmaee M . The relationship between lipid profile and erectile dysfunction. Int J Impot Res 2007; 19: 617.

    CAS  Google Scholar 

  17. Burke JP, Jacobson DJ, McGree ME, Nehra A, Roberts RO, Girman CJ et al. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J Urol 2007; 177: 1438–1442.

    PubMed  Google Scholar 

  18. Riedner CE, Rhoden EL, Ribeiro EP, Fuchs SC . Central obesity is an independent predictor of erectile dysfunction in older men. J Urol 2006; 176 (4 Part 1): 1519–1523.

    PubMed  Google Scholar 

  19. El-Sakka AI . Association of risk factors and medical comorbidities with male sexual dysfunctions. J Sex Med 2007; 4: 1691–1700.

    PubMed  Google Scholar 

  20. He J, Reynolds K, Chen J, Chen CS, Wu X, Duan X et al. Cigarette smoking and erectile dysfunction among Chinese men without clinical vascular disease. Am J Epidemiol 2007; 166: 803–809.

    PubMed  Google Scholar 

  21. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S . Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005; 47: 80–85; discussion 85–86.

    PubMed  Google Scholar 

  22. Barrett-Connor E . Heart disease risk factors predict erectile dysfunction 25 years later (the Rancho Bernardo Study). Am J Cardiol 2005; 96: 3M–7M.

    PubMed  Google Scholar 

  23. Guay AT . ED2: erectile dysfunction=endothelial dysfunction. Endocrinol Metab Clin North Am 2007; 36: 453–463.

    PubMed  Google Scholar 

  24. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R . Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute expert advisory panel. J Sex Med 2005; 2: 40–50; discussion 50–42.

    PubMed  Google Scholar 

  25. Ross R . Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.

    CAS  PubMed  Google Scholar 

  26. Cooke JP . The endothelium: a new target for therapy. Vasc Med (London) 2000; 5: 49–53.

    CAS  Google Scholar 

  27. Lekakis J, Papamichael C, Vemmos C, Stamatelopoulos K, Voutsas A, Stamatelopoulos S . Effects of acute cigarette smoking on endothelium-dependent arterial dilatation in normal subjects. Am J Cardiol 1998; 81: 1225–1228.

    CAS  PubMed  Google Scholar 

  28. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Chayama K, Oshima T . Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens 2001; 14: 1038–1045.

    CAS  PubMed  Google Scholar 

  29. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ . Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179–184.

    Article  PubMed  Google Scholar 

  30. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T . A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl 1988; 6: S188–S191.

    CAS  PubMed  Google Scholar 

  31. Kedzierski RM, Yanagisawa M . Endothelin system: the double-edged sword in health and disease. Ann Rev Pharmacol Toxicol 2001; 41: 851–876.

    CAS  Google Scholar 

  32. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993; 92: 398–403.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172: 1741–1748.

    CAS  PubMed  Google Scholar 

  34. Bohm F, Pernow J . The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007; 76: 8–18.

    PubMed  Google Scholar 

  35. Palmer RM, Ferrige AG, Moncada S . Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–526.

    CAS  PubMed  Google Scholar 

  36. Juonala M, Viikari JS, Alfthan G, Marniemi J, Kahonen M, Taittonen L et al. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circulation 2007; 116: 1367–1373.

    PubMed  Google Scholar 

  37. Ardigo D, Stuehlinger M, Franzini L, Valtuena S, Piatti PM, Pachinger O et al. ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk. Eur J Clin Invest 2007; 37: 263–269.

    CAS  PubMed  Google Scholar 

  38. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001; 358: 2127–2128.

    CAS  PubMed  Google Scholar 

  39. Mittermayer F, Krzyzanowska K, Exner M, Mlekusch W, Amighi J, Sabeti S et al. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 2536–2540.

    CAS  PubMed  Google Scholar 

  40. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 2005; 97: e53–e59.

    CAS  PubMed  Google Scholar 

  41. Elesber AA, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G et al. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 2006; 27: 824–831.

    CAS  PubMed  Google Scholar 

  42. Maas R, Wenske S, Zabel M, Ventura R, Schwedhelm E, Steenpass A et al. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction. Eur Urol 2005; 48: 1004–1011; discussion 1011–1002.

    PubMed  Google Scholar 

  43. Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR . Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J Appl Physiol 2007; 102: 63–71.

    CAS  PubMed  Google Scholar 

  44. Nawawi H, Osman NS, Annuar R, Khalid BA, Yusoff K . Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin. Atherosclerosis 2003; 169: 283–291.

    CAS  PubMed  Google Scholar 

  45. Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S et al. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res 2007; 30: 541–548.

    CAS  PubMed  Google Scholar 

  46. Silvestro A, Brevetti G, Schiano V, Scopacasa F, Chiariello M . Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost 2005; 93: 559–563.

    CAS  PubMed  Google Scholar 

  47. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006; 27: 2640–2648.

    CAS  PubMed  Google Scholar 

  48. Giugliano F, Esposito K, Di Palo C, Ciotola M, Giugliano G, Marfella R et al. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Invest 2004; 27: 665–669.

    CAS  PubMed  Google Scholar 

  49. Billups KL, Kaiser DR, Kelly AS, Wetterling RA, Tsai MY, Hanson N et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res 2003; 15: 231–236.

    CAS  PubMed  Google Scholar 

  50. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336–1342.

    CAS  PubMed  Google Scholar 

  51. Witte DR, Broekmans WM, Kardinaal AF, Klopping-Ketelaars IA, van Poppel G, Bots ML et al. Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis 2003; 170: 147–153.

    CAS  PubMed  Google Scholar 

  52. Bickel C, Rupprecht HJ, Blankenberg S, Espiniola-Klein C, Schlitt A, Rippin G et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89: 901–908.

    CAS  PubMed  Google Scholar 

  53. Naya M, Tsukamoto T, Inubushi M, Morita K, Katoh C, Furumoto T et al. Elevated plasma plasminogen activator inhibitor type-1 is an independent predictor of coronary microvascular dysfunction in hypertension. Circ J 2007; 71: 348–353.

    CAS  PubMed  Google Scholar 

  54. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto Jr AM et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219–4225.

    CAS  PubMed  Google Scholar 

  55. Rader DJ . Inflammatory markers of coronary risk. N Engl J Med 2000; 343: 1179–1182.

    CAS  PubMed  Google Scholar 

  56. Horstman LL, Jy W, Jimenez JJ, Ahn YS . Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118–1135.

    CAS  PubMed  Google Scholar 

  57. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP . Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71–77.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM . Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337–346.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.

    CAS  PubMed  Google Scholar 

  60. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221–228.

    CAS  PubMed  Google Scholar 

  61. Eguchi M, Masuda H, Asahara T . Endothelial progenitor cells for postnatal vasculogenesis. Clin Exp Nephrol 2007; 11: 18–25.

    PubMed  Google Scholar 

  62. Masuda H, Kalka C, Asahara T . Endothelial progenitor cells for regeneration. Hum Cell 2000; 13: 153–160.

    CAS  PubMed  Google Scholar 

  63. Foresta C, Caretta N, Lana A, Cabrelle A, Palu G, Ferlin A . Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 2005; 17: 288–290.

    CAS  PubMed  Google Scholar 

  64. Baumhakel M, Werner N, Bohm M, Nickenig G . Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease. Eur Heart J 2006; 27: 2184–2188.

    PubMed  Google Scholar 

  65. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600.

    PubMed  Google Scholar 

  66. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F . Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93: 2951–2958.

    CAS  PubMed  Google Scholar 

  67. Furumoto T, Fujii S, Saito N, Mikami T, Kitabatake A . Relationships between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease. Jpn Heart J 2002; 43: 117–125.

    PubMed  Google Scholar 

  68. Hashimoto M, Eto M, Akishita M, Kozaki K, Ako J, Iijima K et al. Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 1999; 19: 2795–2800.

    CAS  PubMed  Google Scholar 

  69. Enderle MD, Schroeder S, Ossen R, Meisner C, Baumbach A, Haering HU et al. Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease. Heart 1998; 80: 349–354.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Migdalis IN, Kalogeropoulou K, Karmaniolas KD, Varvarigos N, Mortzos G, Cordopatis P . Plasma levels of endothelin and early carotid atherosclerosis in diabetic patients. Res Commun Mol Pathol Pharmacol 2000; 108: 15–25.

    CAS  PubMed  Google Scholar 

  71. Porta B, Baldassarre D, Camera M, Amato M, Arquati M, Brusoni B et al. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study. Nutr Metab Cardiovasc Dis 2007, advance online publication 21 September 2007 (in press).

  72. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007; 99: 1598–1602.

    PubMed  Google Scholar 

  73. Bocchio M, Scarpelli P, Necozione S, Pelliccione F, Mhialca R, Spartera C et al. Intima-media thickening of common carotid arteries is a risk factor for severe erectile dysfunction in men with vascular risk factors but no clinical evidence of atherosclerosis. J Urol 2005; 173: 526–529.

    PubMed  Google Scholar 

  74. Espeland MA, Craven TE, Riley WA, Corson J, Romont A, Furberg CD . Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group. Stroke 1996; 27: 480–485.

    CAS  PubMed  Google Scholar 

  75. Tee GB, Rasool AH, Halim AS, Rahman AR . Dependence of human forearm skin postocclusive reactive hyperemia on occlusion time. J Pharmacol Toxicol Methods 2004; 50: 73–78.

    CAS  PubMed  Google Scholar 

  76. Belcaro G, Cesarone MR, Nicolaides AN, Vale J, Glass J, Lennox A . Microcirculatory studies in erectile disorders. Curr Med Res Opin 2000; 16 (Suppl 1): s72–s75.

    PubMed  Google Scholar 

  77. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257–265.

    PubMed  Google Scholar 

  78. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235–1241.

    CAS  PubMed  Google Scholar 

  79. Wu WC, Sharma SC, Choudhary G, Coulter L, Coccio E, Eaton CB . Flow-mediated vasodilation predicts the presence and extent of coronary artery disease assessed by stress thallium imaging. J Nucl Cardiol 2005; 12: 538–544.

    PubMed  Google Scholar 

  80. Chiurlia E, D’Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG . Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005; 46: 1503–1506.

    PubMed  Google Scholar 

  81. Yavuzgil O, Altay B, Zoghi M, Gurgun C, Kayikcioglu M, Kultursay H . Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol 2005; 103: 19–26.

    PubMed  Google Scholar 

  82. Kaya C, Uslu Z, Karaman I . Is endothelial function impaired in erectile dysfunction patients? Int J Impot Res 2006; 18: 55–60.

    CAS  PubMed  Google Scholar 

  83. Kuvin JT, Patel AR, Sliney KA . Peripheral arterial tonometry: a simplified technique for assessing endothelium-dependent vasomotion. Program and Abstracts of the American College of Cardiology 50th Annual Scientific Session 18–21. JACC 2001; 37(Suppl): 243A.

    Google Scholar 

  84. Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH . Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med (London) 2007; 12: 13–16.

    Google Scholar 

  85. Bonetti PO, Pumper GM, Higano ST, Holmes Jr DR, Kuvin JT, Lerman A . Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44: 2137–2141.

    PubMed  Google Scholar 

  86. Qureshi E, Diamond GA, Chouraqui P, Saef J, Reed G, Armenia AB et al. Usefulness of finger blood flow during exercise as a marker of functionally significant coronary heart disease. Am J Cardiol 2002; 90: 756–759.

    PubMed  Google Scholar 

  87. Chouraqui P, Schnall RP, Dvir I, Rozanski A, Qureshi E, Arditti A et al. Assessment of peripheral artery tonometry in the detection of treadmill exercise-induced myocardial ischemia. J Am Coll Cardiol 2002; 40: 2195–2200.

    PubMed  Google Scholar 

  88. Rozanski A, Qureshi E, Bauman M, Reed G, Pillar G, Diamond GA . Peripheral arterial responses to treadmill exercise among healthy subjects and atherosclerotic patients. Circulation 2001; 103: 2084–2089.

    CAS  PubMed  Google Scholar 

  89. Goor DA, Sheffy J, Schnall RP, Arditti A, Caspi A, Bragdon EE et al. Peripheral arterial tonometry: a diagnostic method for detection of myocardial ischemia induced during mental stress tests: a pilot study. Clin Cardiol 2004; 27: 137–141.

    PubMed  Google Scholar 

  90. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P . Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006; 101: 545–548.

    CAS  PubMed  Google Scholar 

  91. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003; 146: 168–174.

    PubMed  Google Scholar 

  92. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41: 1761–1768.

    PubMed  Google Scholar 

  93. Haller MJ, Silverstein JH, Shuster JJ . Correlation between radial artery tonometry- and fingertip tonometry-derived augmentation index in children with type 1 diabetes. Diab Vasc Dis Res 2007; 4: 66.

    PubMed  Google Scholar 

  94. Haller MJ, Stein J, Shuster J, Theriaque D, Silverstein J, Schatz DA et al. Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Pediatr Diabetes 2007; 8: 193–198.

    PubMed  Google Scholar 

  95. Shachor-Meyouhas Y, Pillar G, Shehadeh N . Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents. Isr Med Assoc J 2007; 9: 637–640.

    CAS  PubMed  Google Scholar 

  96. Chenzbraun A, Levin G, Scheffy J, Keren A, Stern S, Goor D . The peripheral vascular response to exercise is impaired in patients with risk factors for coronary artery disease. Cardiology 2001; 95: 126–130.

    CAS  PubMed  Google Scholar 

  97. Lowenstein L, Damti A, Pillar G, Shott S, Blumenfeld Z . Evaluation of endothelial function in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2007; 134: 208–212.

    CAS  PubMed  Google Scholar 

  98. Kuvin JT, Karas RH . Clinical utility of endothelial function testing: ready for prime time? Circulation 2003; 107: 3243–3247.

    PubMed  Google Scholar 

  99. Mazo E, Gamidov S, Iremashvili V . The effect of vardenafil on endothelial function of brachial and cavernous arteries. Int J Impot Res 2006; 18: 464–469.

    CAS  PubMed  Google Scholar 

  100. Ucar G, Secil M, Demir O, Demir T, Comlekci A, Uysal S et al. The combined use of brachial artery flow-mediated dilatation and carotid artery intima-media thickness measurements may be a method to determine vasculogenic erectile dysfunction. Int J Impot Res 2007; 19: 577–583.

    CAS  PubMed  Google Scholar 

  101. Khera M, Sathyamoorthy K, Mohamed O, Schumacher M, Ekeruo W, Lipshutz LI . Endothelial function scores can predict which patients will have arterial insufficiency and venous leak on penile duplex ultrasound. J Sex Med 2008; 5 (Suppl 1): 4–41.

    Google Scholar 

  102. Montorsi P, Montorsi F, Schulman CC . Is erectile dysfunction the ‘tip of the iceberg’ of a systemic vascular disorder? Eur Urol 2003; 44: 352–354.

    PubMed  Google Scholar 

  103. Jackson G, Rosen RC, Kloner RA, Kostis JB . The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 2006; 3: 28–36; discussion 36.

    CAS  PubMed  Google Scholar 

  104. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005; 96: 85M–93M.

    PubMed  Google Scholar 

  105. Smith NJ, Sak SC, Baldo O, Eardley I . The prevalence of newly diagnosed hyperlipidaemia in men with erectile dysfunction. BJU Int 2007; 100: 357–361.

    CAS  PubMed  Google Scholar 

  106. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–1404.

    CAS  PubMed  Google Scholar 

  107. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM . Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 159: 2164–2171.

    CAS  PubMed  Google Scholar 

  108. Beavo JA . Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725–748.

    CAS  PubMed  Google Scholar 

  109. Sommer F, Schulze W . Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors. World J Urol 2005; 23: 385–392.

    CAS  PubMed  Google Scholar 

  110. Behr-Roussel D, Gorny D, Mevel K, Caisey S, Bernabe J, Burgess G et al. Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol 2005; 47: 87–91.

    CAS  PubMed  Google Scholar 

  111. McMahon C . Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J Sex Med 2004; 1: 292–300.

    CAS  PubMed  Google Scholar 

  112. McMahon C . Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. J Sex Med 2005; 2: 415–425; discussion 425–417.

    CAS  PubMed  Google Scholar 

  113. Foresta C, Lana A, Cabrelle A, Ferigo M, Caretta N, Garolla A et al. PDE-5 inhibitor, vardenafil, increases circulating progenitor cells in humans. Int J Impot Res 2005; 17: 377–380.

    CAS  PubMed  Google Scholar 

  114. Foresta C, Ferlin A, De Toni L, Lana A, Vinanzi C, Galan A et al. Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction. Int J Impot Res 2006; 18: 484–488.

    CAS  PubMed  Google Scholar 

  115. Bocchio M, Pelliccione F, Passaquale G, Mihalca R, Necozione S, Desideri G et al. Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. Atherosclerosis 2008; 196: 313–319.

    CAS  PubMed  Google Scholar 

  116. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G . Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 2007; 19: 200–207.

    CAS  PubMed  Google Scholar 

  117. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G . Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005; 47: 214–220; discussion 220–212.

    CAS  PubMed  Google Scholar 

  118. Proietti M, Aversa A, Letizia C, Rossi C, Menghi G, Bruzziches R et al. Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. J Rheumatol 2007; 34: 1712–1717.

    CAS  PubMed  Google Scholar 

  119. Aversa A, Bruzziches R, Vitale C, Marazzi G, Francomano D, Barbaro G et al. Chronic sildenafil in men with diabetes and erectile dysfunction. Expert Opin Drug Metabol Toxicol 2007; 3: 451–464.

    CAS  Google Scholar 

  120. Aversa A, Vitale C, Volterrani M, Fabbri A, Spera G, Fini M et al. Chronic administration of sildenafil improves markers of endothelial function in men with type 2 diabetes. Diabet Med 2008; 25: 37–44.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Mount Sinai Men's Wellness Program, The Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, NY, USA

    R Tamler & N Bar-Chama

Authors
  1. R Tamler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Bar-Chama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to R Tamler or N Bar-Chama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamler, R., Bar-Chama, N. Assessment of endothelial function in the patient with erectile dysfunction: an opportunity for the urologist. Int J Impot Res 20, 370–377 (2008). https://doi.org/10.1038/ijir.2008.13

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2008.13

Keywords

This article is cited by

Search

Advanced search

Quick links